Year |
Citation |
Score |
2020 |
Sahni JM, Gayle SS, Bonk KLW, Vite LC, Yori JL, Webb B, Ramos EK, Seachrist DD, Landis MD, Chang JC, Bradner JE, Keri RA. Correction: Bromodomain and extraterminal protein inhibition blocks growth of triple-negative breast cancers through the suppression of aurora kinases. The Journal of Biological Chemistry. 295: 9266. PMID 33516519 DOI: 10.1074/jbc.AAC120.014699 |
0.744 |
|
2020 |
Sahni JM, Gayle SS, Bonk KLW, Vite LC, Yori JL, Webb B, Ramos EK, Seachrist DD, Landis MD, Chang JC, Bradner JE, Keri RA. Correction: Bromodomain and extraterminal protein inhibition blocks growth of triple-negative breast cancers through the suppression of aurora kinases. The Journal of Biological Chemistry. 295: 9266. PMID 32620694 DOI: 10.1074/jbc.AAC120.014699 |
0.744 |
|
2018 |
Liao P, Yori J, Keri R, Koyuturk M, Barnholtz-Sloan J. Abstract 2262: Inference of kinase activity for cancer phosphoproteomics using substrate prediction scores Cancer Research. 78: 2262-2262. DOI: 10.1158/1538-7445.Am2018-2262 |
0.673 |
|
2016 |
Sahni JM, Gayle SS, Weber-Bonk KL, Cuellar Vite L, Yori JL, Webb B, Ramos EK, Seachrist DD, Landis MD, Chang JC, Bradner JE, Keri RA. Bromodomain and extraterminal protein inhibition blocks growth of triple-negative breast cancers through the suppression of Aurora kinases. The Journal of Biological Chemistry. PMID 27650498 DOI: 10.1074/Jbc.M116.738666 |
0.727 |
|
2014 |
Yori JL, Lozada KL, Seachrist DD, Mosley JD, Abdul-Karim FW, Booth CN, Flask CA, Keri RA. Combined SFK/mTOR inhibition prevents rapamycin-induced feedback activation of AKT and elicits efficient tumor regression. Cancer Research. 74: 4762-71. PMID 25023728 DOI: 10.1158/0008-5472.Can-13-3627 |
0.771 |
|
2013 |
Yori JL, Lozada K, Seachrist DD, Mosley J, Abdul-Karim FW, Booth CN, Flask CA, Keri RA. Abstract LB-221: Inhibition of rapamycin-induced feedback activation of AKT with dasatinib induces complete tumor regression in a preclinical model of breast cancer. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-221 |
0.768 |
|
2011 |
Yori JL, Seachrist DD, Johnson E, Lozada KL, Abdul-Karim FW, Chodosh LA, Schiemann WP, Keri RA. Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia (New York, N.Y.). 13: 601-10. PMID 21750654 DOI: 10.1593/Neo.11260 |
0.726 |
|
2010 |
Yori JL, Johnson E, Zhou G, Jain MK, Keri RA. Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. The Journal of Biological Chemistry. 285: 16854-63. PMID 20356845 DOI: 10.1074/Jbc.M110.114546 |
0.647 |
|
Show low-probability matches. |